**
Bristol Myers Squibb is seeking an Associate Director for US Multiple Myeloma Cell Therapy Marketing to lead strategic marketing initiatives and launch preparations for arlo-cel. The ideal candidate will have significant experience in pharmaceutical marketing, particularly in oncology or cell therapy, and will leverage data-driven insights to drive brand success.
**
Job Summary
This role is a key member of the US Cell Therapy Organization contributing to the launch preparation for arlo-cel (GPRC5D).
The position requires driving strategic planning and execution of HCP marketing initiatives while leveraging data to turn insights into action.
Bristol Myers Squibb offers competitive benefits including health coverage, financial well-being programs, and flexible time off options.
Matching Summary
Match Score: 75
**
Bristol Myers Squibb is seeking an Associate Director for US Multiple Myeloma Cell Therapy Marketing to lead strategic marketing initiatives and launch preparations for arlo-cel. The ideal candidate will have significant experience in pharmaceutical marketing, particularly in oncology or cell therapy, and will leverage data-driven insights to drive brand success.
**
Salary
Base: $164,990 - $199,933; Bonus/Equity: Additional incentive cash and stock opportunities available; Benefits: Comprehensive health, 401(k), paid time off, and wellbeing support
Skills & Requirements
Must-have
7-10 years pharmaceutical marketing experience
US brand launch execution expertise
Omnichannel marketing strategy development
Cross-functional team leadership
HCP insights and data analytics
Nice-to-have
Multiple Myeloma therapeutic area experience
Cell Therapy background preferred
Strong scientific acumen
Innovative problem-solving skills
Matrixed environment collaboration
Key Requirements
Bachelor's degree required; MBA or Advanced Degree strongly preferred
Minimum 7-10 years progressive experience in pharma/biotech marketing
Proven track record of US launch or in-line brand execution
Experience with FDA promotional regulations and PhRMA guidelines